Drug Deal: Nxera Pharma struck a global licensing deal with AbbVie for an experimental oral inflammatory bowel disease drug, securing $100 million upfront and eligibility for up to $1.37 billion in milestones, plus royalties. Medicine Supply: AGC Biologics expanded a manufacturing agreement with an unnamed drugmaker to more than €500 million, adding six biologics programs at its Copenhagen site to production plans in Japan. Patient Privacy: The Philippines’ privacy regulator is reviewing a breach at St. Luke’s Medical Center that may have exposed patient and employee data; the hospital says it is notifying those affected. Medical Debt: Kentucky says $153 million in medical debt has been erased for 67,000 residents, as the state works toward a $250 million relief goal. Food and Health: A small New York study linked medically tailored meals with improved blood sugar and blood pressure in adults with diabetes and hypertension, but its lack of a comparison group means it cannot show the meals caused the changes. Antibiotic Resistance: India’s health minister urged pharmacists to discourage unnecessary antibiotic use and counsel patients to take medicines as prescribed.